137 related articles for article (PubMed ID: 15652456)
41. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck.
Begum S; Gillison ML; Nicol TL; Westra WH
Clin Cancer Res; 2007 Feb; 13(4):1186-91. PubMed ID: 17317828
[TBL] [Abstract][Full Text] [Related]
42. Genetic factors associated with head and neck cancer.
Br Dent J; 2007 Jan; 202(2):58. PubMed ID: 17255975
[No Abstract] [Full Text] [Related]
43. Expression of p63, COX-2, EGFR and beta-catenin in smokers and patients with squamous cell carcinoma of the head and neck reveal variations in non-neoplastic tissue and no obvious changes in smokers.
Boldrup L; Coates PJ; Hedberg Y; Sjöström B; Dahlqvist A; Nylander K
Int J Oncol; 2005 Dec; 27(6):1661-7. PubMed ID: 16273222
[TBL] [Abstract][Full Text] [Related]
44. [Loss of heterozygosity as a tool in the evaluation of cancer risk in premalignant lesions of the head and neck].
Soria JC
Bull Cancer; 2000 Jun; 87(6):446. PubMed ID: 10903785
[No Abstract] [Full Text] [Related]
45. Metastatic cutaneous squamous cell carcinoma to the parotid and cervical lymph nodes: treatment and outcomes.
Bumpous J
Curr Opin Otolaryngol Head Neck Surg; 2009 Apr; 17(2):122-5. PubMed ID: 19346945
[TBL] [Abstract][Full Text] [Related]
46. Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer.
Gattás GJ; de Carvalho MB; Siraque MS; Curioni OA; Kohler P; Eluf-Neto J; Wünsch-Filho V
Head Neck; 2006 Sep; 28(9):819-26. PubMed ID: 16721740
[TBL] [Abstract][Full Text] [Related]
47. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck.
Zhang Z; Wang LE; Sturgis EM; El-Naggar AK; Hong WK; Amos CI; Spitz MR; Wei Q
Clin Cancer Res; 2006 Sep; 12(18):5596-602. PubMed ID: 17000697
[TBL] [Abstract][Full Text] [Related]
48. The molecular biology of mucosal field cancerization of the head and neck.
Ha PK; Califano JA
Crit Rev Oral Biol Med; 2003; 14(5):363-9. PubMed ID: 14530304
[TBL] [Abstract][Full Text] [Related]
49. Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression.
Patel V; Hood BL; Molinolo AA; Lee NH; Conrads TP; Braisted JC; Krizman DB; Veenstra TD; Gutkind JS
Clin Cancer Res; 2008 Feb; 14(4):1002-14. PubMed ID: 18281532
[TBL] [Abstract][Full Text] [Related]
50. Phenotypic and genotypic disparity in premalignant lesions: of calm water and crocodiles.
Westra WH; Sidransky D
J Natl Cancer Inst; 1998 Oct; 90(20):1500-1. PubMed ID: 9790536
[No Abstract] [Full Text] [Related]
51. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer.
O-Charoenrat P; Khantapura P
Oral Oncol; 2006 Mar; 42(3):257-67. PubMed ID: 16275157
[TBL] [Abstract][Full Text] [Related]
52. Significance of ceramide and DNA ploidy in laryngeal carcinogenesis.
Yuan Y; Chi F; Wang S; Wang Z
ORL J Otorhinolaryngol Relat Spec; 2007; 69(5):283-8. PubMed ID: 17565231
[TBL] [Abstract][Full Text] [Related]
53. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.
Chen K; Hu Z; Wang LE; Sturgis EM; El-Naggar AK; Zhang W; Wei Q
Carcinogenesis; 2007 Sep; 28(9):2008-12. PubMed ID: 17693666
[TBL] [Abstract][Full Text] [Related]
54. Immunotherapy in head and neck cancer: current practice and future possibilities.
Agada FO; Alhamarneh O; Stafford ND; Greenman J
J Laryngol Otol; 2009 Jan; 123(1):19-28. PubMed ID: 18761763
[TBL] [Abstract][Full Text] [Related]
55. Role of nitric oxide in the development of distant metastasis from squamous cell carcinoma.
Scher RL
Laryngoscope; 2007 Feb; 117(2):199-209. PubMed ID: 17277613
[TBL] [Abstract][Full Text] [Related]
56. Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer.
Kudo Y; Ogawa I; Kitajima S; Kitagawa M; Kawai H; Gaffney PM; Miyauchi M; Takata T
Cancer Res; 2006 Jul; 66(14):6928-35. PubMed ID: 16849536
[TBL] [Abstract][Full Text] [Related]
57. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
58. Molecular changes in the multistage pathogenesis of head and neck cancer.
Park BJ; Chiosea SI; Grandis JR
Cancer Biomark; 2010; 9(1-6):325-39. PubMed ID: 22112483
[TBL] [Abstract][Full Text] [Related]
59. Prevention of head and neck cancer: current status and future prospects.
Jain S; Khuri FR; Shin DM
Curr Probl Cancer; 2004; 28(5):265-86. PubMed ID: 15375804
[No Abstract] [Full Text] [Related]
60. Multiple head and neck tumors frequently originate from a single preneoplastic lesion.
Tabor MP; Brakenhoff RH; Ruijter-Schippers HJ; Van Der Wal JE; Snow GB; Leemans CR; Braakhuis BJ
Am J Pathol; 2002 Sep; 161(3):1051-60. PubMed ID: 12213734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
